What the study found
Researchers at Keck Medicine of USC report that fish oil supplements did not protect memory or thinking skills in older adults at elevated risk of Alzheimer's disease, even though the omega-3 fatty acid they contained reached the brain's surrounding fluid. The results were published in the journal eBioMedicine, according to Science Daily.
Participants who took the supplement every day performed no better on cognitive tests than those given a placebo after two years. Brain imaging also showed no sign that the supplements slowed shrinkage of the hippocampus, a deep brain region central to forming and organizing memories and one that is especially vulnerable to aging and Alzheimer's.
"We all wish there was a silver bullet for preventing Alzheimer's, but our findings showed that fish oil supplements do not appear to protect brain health," said Hussein Naji Yassine, MD, director of the USC Center for Personalized Brain Health and lead investigator.
How the trial was designed
The study enrolled 365 adults between 55 and 80 who rarely ate fish, a major dietary source of omega-3s, and who were considered at higher risk of Alzheimer's. Nearly half, 47%, carried APOE4, a gene variant described as the strongest known genetic risk factor for late-onset Alzheimer's, though carrying it does not guarantee someone will develop the disease.
Volunteers were randomly assigned to take either a daily fish oil supplement providing 2,000 mg of docosahexaenoic acid, or DHA, or a placebo. DHA is an omega-3 that is a major component of brain cell membranes and supports communication between nerve cells. The trial was double-blind, so neither participants nor researchers knew who received the active supplement, a design meant to reduce bias.
Omega-3 reached the brain, but without a payoff
Before judging any benefit, the team checked whether the DHA was actually getting into the central nervous system. They measured it in cerebrospinal fluid, the liquid that surrounds and cushions the brain and spinal cord. After six months, DHA levels there had risen by an average of 17% among those taking the supplements.
Cognitive testing at the start and again at two years, along with the imaging results, showed that this increase did not translate into measurable gains. The researchers concluded that simply raising DHA availability in the brain was not enough to produce cognitive benefits in this group of older adults.
Diet, lifestyle and the open questions
The findings do not mean omega-3s are unnecessary or that eating fish offers no health benefit, according to the report. They indicate only that high-dose DHA supplements alone did not provide measurable protection against cognitive decline or hippocampal shrinkage in the people studied.
Yassine and colleagues are now examining how the brain absorbs and uses omega-3s. Their earlier research suggests the nutrients may work better as part of a broader dietary pattern, such as a Mediterranean-style diet built around fish, vegetables, fruits, whole grains, legumes, nuts and olive oil, which has been associated with a lower risk of Alzheimer's. "We are working to develop medications that may help the brain better utilize these nutrients to preserve cognitive function," Yassine said.
He also stressed general habits. "Staying healthy throughout life remains the most powerful tool we have for reducing Alzheimer's risk, including regular exercise, quality sleep and a balanced diet," he said. Those lifestyle factors were not directly tested in the trial, the researchers noted, but they believe such habits offer a more promising foundation than relying on fish oil alone.
